Media Thread, page-13615

The FDA is a massive bureaucracy, and whilst their performance in regard to the mNRA covid shots was unspeakable, it is entirely possible that sections and sub-sections of the "empire" will have a supportive view of emerging science in Oncology. This is particularly the case as BP will build massive revenue streams with any and all new drugs that are developed. The current US centric system is particularly advantageous to BP, and both the FDA and many in the BP universe will want more efficacious drugs to be available due to the catastrophic increase in the incidence of cancer post the diabolical mismanagement of Covid around the Western world. I have a very sceptical (indeed pessimistic) view of the regulation of both Covid "vaccines" (and drugs more generally) by food and drug regulators around the western world, but IMU's progress allows for some optimism.
My opinion only. DYOR.